Lior Rosenberg

Original Research

An Open-Label, Proof-of-Concept Study Assessing the Effects of Bromelain-Based Enzymatic Debridement on Biofilm and Microbial Loads in Patients With Venous Leg Ulcers and Diabetic Foot Ulcers

12/20/2023

Robert J. Snyder , MD, PhD, DPM, FACFAS, CWS-P, MBA;

Adam J. Singer ;

Cyaandi R. Dove , DPM;

Yaron Shoham ;

Edward Grant ;

Garth A. James ;

Aya Ben Yaakov ;

Stephen Heisler ;

Elinor deLancey Pulcini ;

Lior Rosenberg ;

Howard Petusevsky ;

This study examines the efficacy of a bromelain-based debridement agent for reduction of biofilm in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.

This study examines the efficacy...

12/20/2023

Wounds

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

March 23 ⁠–⁠ March 24

April 27 ⁠–⁠ April 28

Great Debates & Updates in Diabetic Foot

November 30 ⁠–⁠ December 2

November 27 ⁠–⁠ November 29

December 12 ⁠–⁠ December 13

May 13 ⁠–⁠ May 14

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Lior Rosenberg

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products